Authors:
SPARREBOOM A
DEBRUIJN P
DEJONGE MJA
LOOS WJ
STOTER G
VERWEIJ J
NOOTER K
Citation: A. Sparreboom et al., LIQUID-CHROMATOGRAPHIC DETERMINATION OF IRINOTECAN AND 3 MAJOR METABOLITES IN HUMAN PLASMA, URINE AND FECES, Journal of chromatography B. Biomedical sciences and applications, 712(1-2), 1998, pp. 225-235
Authors:
SPARREBOOM A
DEBRUIJN P
NOOTER K
LOOS WJ
STOTER G
VERWEIJ J
Citation: A. Sparreboom et al., DETERMINATION OF PACLITAXEL IN HUMAN PLASMA USING SINGLE SOLVENT-EXTRACTION PRIOR TO ISOCRATIC REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical sciences and applications, 705(1), 1998, pp. 159-164
Authors:
SPARREBOOM A
DEJONGE MJA
DEBRUIJN P
BROUWER E
NOOTER K
LOOS WJ
VANALPHEN RJ
MATHIJSSEN RHJ
STOTER G
VERWEIJ J
Citation: A. Sparreboom et al., IRINOTECAN (CPT-11) METABOLISM AND DISPOSITION IN CANCER-PATIENTS, Clinical cancer research, 4(11), 1998, pp. 2747-2754
Authors:
SPARREBOOM A
DEBRUIJN P
DEJONGE MJA
LOOS WJ
NOOTER K
STOTER G
VERWEIJ J
Citation: A. Sparreboom et al., LIQUID-CHROMATOGRAPHIC DETERMINATION OF IRINOTECAN (CPT-11) AND ITS MAJOR METABOLITES IN HUMAN PLASMA, URINE AND FECES, Annals of oncology, 9, 1998, pp. 219-219
Authors:
SPARREBOOM A
PLANTING AST
JEWELL RC
PAUL EM
WISSEL PS
DEBRUIJN P
NOOTER K
STOTER G
VERWEIJ J
Citation: A. Sparreboom et al., CLINICAL PHARMACOKINETICS OF DOXORUBICIN IN COMBINATION WITH GF120918, A POTENT INHIBITOR OF MDR1 P-GLYCOPROTEIN, Annals of oncology, 9, 1998, pp. 550-550
Authors:
DEBRUIJN P
VERWEIJ J
LOOS WJ
NOOTER K
STOTER G
SPARREBOOM A
Citation: P. Debruijn et al., DETERMINATION OF IRINOTECAN (CPT-11) AND ITS ACTIVE METABOLITE SN-38 IN HUMAN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION, Journal of chromatography B. Biomedical sciences and applications, 698(1-2), 1997, pp. 277-285
Authors:
VANDEGRAAF AA
DEBRUIJN P
ROBERTSON LA
JETTEN MSM
KUENEN JG
Citation: Aa. Vandegraaf et al., METABOLIC PATHWAY OF ANAEROBIC AMMONIUM OXIDATION ON THE BASIS OF N-15 STUDIES IN A FLUIDIZED-BED REACTOR, Microbiology, 143, 1997, pp. 2415-2421
Authors:
DEJONGE MJA
SPARREBOOM A
PLANTING AST
VANDERBURG MEL
DEBRUIJN P
BROUWER E
VANBEURDEN V
VANDUIJN MR
JACQUES C
VERWEIJ J
Citation: Mja. Dejonge et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF IRINOTECAN (CPT-11) AND CISPLATIN IN PATIENTS WITH SOLID TUMORS - PRELIMINARY-RESULTS, European journal of cancer, 33, 1997, pp. 1134-1134
Authors:
DEVOS AI
NOOTER K
VERWEIJ J
LOOS WL
BROUWER E
DEBRUIJN P
RUIJGROK EJ
VANDERBURG MEL
STOTER G
SPARREBOOM A
Citation: Ai. Devos et al., DIFFERENTIAL MODULATION OF CISPLATIN ACCUMULATION IN LEUKOCYTES AND TUMOR-CELL LINES BY THE PACLITAXEL VEHICLE CREMOPHOR EL, Annals of oncology, 8(11), 1997, pp. 1145-1150
Citation: Msm. Jetten et al., HYDROXYLAMINE METABOLISM IN PSEUDOMONAS PB16 - INVOLVEMENT OF A NOVELHYDROXYLAMINE OXIDOREDUCTASE, Antonie van Leeuwenhoek, 71(1-2), 1997, pp. 69-74
Authors:
DEGRAAF AAV
DEBRUIJN P
ROBERTSON LA
JETTEN MSM
KUENEN JG
Citation: Aav. Degraaf et al., AUTOTROPHIC GROWTH OF ANAEROBIC AMMONIUM-OXIDIZING MICROORGANISMS IN A FLUIDIZED-BED REACTOR, Microbiology, 142, 1996, pp. 2187-2196
Authors:
VANDEGRAAF AA
MULDER A
DEBRUIJN P
JETTEN MSM
ROBERTSON LA
KUENEN JG
Citation: Aa. Vandegraaf et al., ANAEROBIC OXIDATION OF AMMONIUM IS A BIOLOGICALLY MEDIATED PROCESS, Applied and environmental microbiology, 61(4), 1995, pp. 1246-1251